These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 10561188

  • 1. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life.
    Bow EJ, Kilpatrick MG, Clinch JJ.
    J Clin Oncol; 1999 Apr; 17(4):1267. PubMed ID: 10561188
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R, Corrado F, de Braud F, de Lucia F, Scarpa D, Testori A, Orsi F, Bellomi M, Mauri S, Aapro M, Andreoni B.
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Health-related quality of life in patients with solid tumors receiving implantable venous access ports for chemotherapy: A prospective randomized controlled trial.
    Chrisanthopoulou P, Iconomou G, Assimakopoulos K, Vlachopoulos G, Makatsoris T, Koutras A, Karnabatidis D, Katsanos K.
    Eur J Oncol Nurs; 2023 Dec; 67():102445. PubMed ID: 37871414
    [Abstract] [Full Text] [Related]

  • 9. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports.
    Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA.
    Am J Surg; 2004 Dec; 188(6):722-7. PubMed ID: 15619490
    [Abstract] [Full Text] [Related]

  • 10. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A, Rasero L, Guerretta L, Perfetti E, Clerico M.
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [Abstract] [Full Text] [Related]

  • 11. Cost effectiveness of different central venous approaches for port placement and use in adult oncology patients: evidence from a randomized three-arm trial.
    Biffi R, Pozzi S, Bonomo G, Della Vigna P, Monfardini L, Radice D, Rotmensz N, Zampino MG, Fazio N, Orsi F.
    Ann Surg Oncol; 2014 Nov; 21(12):3725-31. PubMed ID: 24841352
    [Abstract] [Full Text] [Related]

  • 12. Radiologic placement of long-term central venous peripheral access system ports (PAS Port): results in 150 patients.
    Foley MJ.
    J Vasc Interv Radiol; 1995 Nov; 6(2):255-62. PubMed ID: 7787360
    [Abstract] [Full Text] [Related]

  • 13. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients.
    Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, Rotmensz N, Robertson C, Bellomi M, Andreoni B.
    Cancer; 2001 Sep 01; 92(5):1204-12. PubMed ID: 11571734
    [Abstract] [Full Text] [Related]

  • 14. Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman.
    D'Souza PC, Kumar S, Kakaria A, Al-Sukaiti R, Al-Baimani K, Hamid RS, Mittal AK, Al-Balushi M, Burney IA, Al-Moundhri MS.
    Sultan Qaboos Univ Med J; 2021 Feb 01; 21(1):e103-e109. PubMed ID: 33777430
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies.
    Kreis H, Loehberg CR, Lux MP, Ackermann S, Lang W, Beckmann MW, Fasching PA.
    Eur J Surg Oncol; 2007 Feb 01; 33(1):39-43. PubMed ID: 17029869
    [Abstract] [Full Text] [Related]

  • 17. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
    Ng F, Mastoroudes H, Paul E, Davies N, Tibballs J, Hochhauser D, Mayer A, Begent R, Meyer T.
    Clin Oncol (R Coll Radiol); 2007 Sep 01; 19(7):551-6. PubMed ID: 17517500
    [Abstract] [Full Text] [Related]

  • 18. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
    Narducci F, Jean-Laurent M, Boulanger L, El Bédoui S, Mallet Y, Houpeau JL, Hamdani A, Penel N, Fournier C.
    Eur J Surg Oncol; 2011 Oct 01; 37(10):913-8. PubMed ID: 21831566
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
    Chang YF, Lo AC, Tsai CH, Lee PY, Sun S, Chang TH, Chen CC, Chang YS, Chen JR.
    Palliat Med; 2013 Feb 01; 27(2):185-91. PubMed ID: 22126844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.